Skip to main content
SpringerLink
Log in

Management of Community-Acquired Pneumonia in Children

  • Therapy In Practice
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

Community-acquired pneumonia (CAP) is a significant cause of childhood morbidity and mortality worldwide. Viral etiology is most common in young children and decreases with age. Streptococcus pneumoniae is the single most common bacterial cause across all age groups. Atypical organisms present similarly across all age groups and may be more common than previously recognized.

A bacterial pneumonia should be considered in children presenting with fever >38.5°C, tachypnea, and chest recession. Oxygen therapy is life saving and should be given when oxygen saturation is <92%. For non-severe pneumonia, oral amoxicillin is the antibacterial of choice with low failure rates reported. Severely ill children are traditionally treated with parenteral antibacterials. Penicillin non-susceptible S. pneumoniae prevalence rates are increasing and have been linked to community antibacterial prescribing. Most pneumococci remain sensitive to high-dose penicillin-based antibacterials but macrolide resistance is also a problem in some communities. However, primary combination treatment with macrolides is indicated in areas where there is a high prevalence of atypical organisms. The most common complications in CAP are parapneumonic effusions and empyema. The use of ultrasonography combined with intercostal drainage augmented with the use of fibrinolytic therapy has significantly reduced the morbidity associated with these complications. There is increasing evidence that a preventative strategy with the 7-valent pneumococcal conjugate vaccine (PCV-7) results in a significant fall in CAP in early childhood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Mandell LA, Marrie TJ, Grossmann RF, et al. Canadian guidelines for initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infecious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis 2000; 31(2): 383–42

    Article  PubMed  CAS  Google Scholar 

  2. British Thoracic Society. British Thoracic Society guidelines for management of community acquired pneumonia in childhood. Thorax 2002; 57Suppl. 1: i1–24

    Google Scholar 

  3. Zar HJ, Jeena P, Argent A, et al., Working Groups of the Paediatric Assembly of the South African Thoracic Society. Diagnosis and management of community-acquired pneumonia in childhood: South African Thoracic Society guidelines. S Afr Med J 2005; 95 (12 Pt 2): 977–90

    PubMed  CAS  Google Scholar 

  4. McIntosh K. Community acquired pneumonia in children. N Engl J Med 2002; 346: 430–7

    Article  Google Scholar 

  5. Jokien C, Heiskanen L, Juvoenen H. Incidence of community acquired pneumonia in the population of four municipalities in Eastern Finland. Am J Epidemiol 1993; 137: 977–88

    Google Scholar 

  6. Weigl JA, Puppe W, Belke O, et al. Population-based incidence of severe pneumonia in children in Kiel, Germany. Klin Padiatr 2005; 217(4): 211–9

    Article  PubMed  CAS  Google Scholar 

  7. Bryce J, Boschi-Pinto C, Shibuya K, et al. WHO estimates of the causes of death in children. Lancet 2005; 365: 1147–52

    Article  PubMed  Google Scholar 

  8. Clements H, Stephenson T, Gabriel V, et al. Rationalised prescribing for community-acquired pneumonia: a closed loop audit. Arch Dis Child 2000; 83: 320–4

    Article  PubMed  CAS  Google Scholar 

  9. Gendrel D, Raymond J, Moulin F, et al. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children. Eur J Clin Microbiol Infect Dis 1997; 16: 388–91

    Article  PubMed  CAS  Google Scholar 

  10. Juven T, Mertsola J, Waris M, et al. Etiology of community-acquired pneumonia in 254 hospitalised children. Pediatr Infect Dis J 2000; 19: 293–8

    Article  PubMed  CAS  Google Scholar 

  11. Drummond P, Clark J, Wheeler J, et al. Community acquired pneumonia: a prospective UK study. Arch Dis Child 2000; 83(5): 408–12

    Article  PubMed  CAS  Google Scholar 

  12. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004; 113(4): 701–7

    Article  PubMed  Google Scholar 

  13. Don M, Fasoli L, Paldanius M, et al. Aetiology of community-acquired pneumonia: serological results of a paediatric survey. Scand J Infect Dis 2005; 37(11–12): 806–12

    Article  PubMed  Google Scholar 

  14. Poehling KA, Lafleur BJ, Szilagyi PG, et al. Population-based impact of pneumococcal conjugate vaccine in young children. Pediatrics 2004; 114(3): 755–61

    Article  PubMed  Google Scholar 

  15. Esposito S, Blasi F, Bellini F, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia. Eur Respir J 2001; 17: 241–5

    Article  PubMed  CAS  Google Scholar 

  16. Somer A, Salman N. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia in Istanbul, Turkey. J Trop Pediatr 2006; 52(3): 173–8

    Article  PubMed  Google Scholar 

  17. World Health Organization. The management of acute respiratory infections in children. In: Practical guidelines for outpatient care. Geneva: WHO, 1995

    Google Scholar 

  18. Palafox M, Guiscafre H, Reyes H, et al. Dignostic value of tachypnea in pneumonia defined radiologically. Arch Dis Child 2000; 82: 41–5

    Article  PubMed  CAS  Google Scholar 

  19. Hansen J, Black S, Shinefield H, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J 2006; 25(9): 779–81

    Article  PubMed  Google Scholar 

  20. Swingler GH, Zwarenstein M. Chest radiograph in acute respiratory infections in children. Cochrane Database Syst Rev 2000; (2): CD001268

    Google Scholar 

  21. Virkki R, Juven T, Mertsola J, et al. Radiological follow-up of pneumonia in children. Ped Pulm 2005; 40(3): 223–7

    Article  CAS  Google Scholar 

  22. Korppi M, Heiskanen-Kosma T, Leionen M. White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children. Eur Respir J 1997; 10: 1125–9

    Article  PubMed  CAS  Google Scholar 

  23. Virkki R, Juven T, Rikalainen H, et al. Differentiation of bacterial and viral pneumonia in children. Thorax 2002; 57: 438–41

    Article  PubMed  CAS  Google Scholar 

  24. Korppi M. Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination? Pediatr Int 2004; 46(5): 545–50

    Article  PubMed  Google Scholar 

  25. Korppi M, Katila ML, Kalliokoski R, et al. Pneumococcal finding in a sample from upper airways does not indicate pneumococcal infection in lower airways. Scand J Infect Dis 1992; 24(4): 445–51

    Article  PubMed  CAS  Google Scholar 

  26. Ruuuskanen O, Nohynek H, Ziegler T, et al. Pneumonia in childhood: etiology and response to antimicrobial therapy. Eur J Clin Microbiol Infect Dis 1992; 11: 217–23

    Article  Google Scholar 

  27. Navarro D, Garcia-Maset L, Gimeno C, et al., Spanish Pneumococcal Infection Study Network. Performance of the Binax NOW Streptococcus pneumoniae urinary antigen assay for diagnosis of pneumonia in children with underlying pulmonary diseases in the absence of acute pneumococcal infection. J Clin Microbiol 2004 Oct; 42(10): 4853–5

    Article  PubMed  Google Scholar 

  28. Requejo HI, Guerra MI, Dos Santos M, et al. Immunodiagnoses of community-acquired pneumonia in childhood. J Trop Pediatr 1997; 43: 208–12

    Article  PubMed  CAS  Google Scholar 

  29. Smyth A, Carty H, Hart CA. Clinical predictors of hypoxaemia in children with pneumonia. Ann Trop Paediatr 1998; 18: 31–40

    PubMed  CAS  Google Scholar 

  30. Haviv M, Haver E, Lichstein D, et al. Atrial natriuretic peptite in children with pneumonia. Pediatr Pulmonol 2005; 40(4): 306–9

    Article  PubMed  Google Scholar 

  31. Huiming Y, Chaomin W, Meng M. Vitamin A for treating measles in children. Cochrane Database Syst Rev 2005; (4): CD001479

    Google Scholar 

  32. Brown N, Roberts C. Vitamin A for acute respiratory infection in developing countries: a meta-analysis. Acta Paediatr 2004; 93(11): 1437–42

    Article  PubMed  CAS  Google Scholar 

  33. Brooks WA, Yunus M, Santosham M, et al. Zinc for severe pneumonia in very young children: double-blind placebo-controlled trial. 2004; 363(9422): 1683–8

    CAS  Google Scholar 

  34. Bose A, Coles CL, Gunavathi, et al. Efficacy of zinc in the treatment of severe pneumonia in hospitalized children <2y old. Am J Clin Nutr 2006; 83(5): 1089–96

    PubMed  CAS  Google Scholar 

  35. Chang AB, Torzillo PJ, Boyce NC, et al. Zince and vitamin A supplementation in Indigenous Australian children hospitalized with lower respiratory tract infection: a randomized controlled trial. Med J Aust 2006; 184(3): 107–12

    PubMed  Google Scholar 

  36. Friss B, Andersen P, Brenoe E, et al. Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomized study. Arch Dis Child 1984; 59: 1038–45

    Article  Google Scholar 

  37. Little P, Rumsby K, Kelly J, et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection. JAMA 2005; 293: 3029–35

    Article  PubMed  CAS  Google Scholar 

  38. Kabra SK, Lodha R, Pandey RM. Antibiotics for community acquired pneumonia in children. Cochrane Database Syst Rev 2006; (3): CD004874

    Google Scholar 

  39. Vuori-Holopainen E, Peltola H, Kallio MJ, SE-TU Study Group. Narrow-versus broad-spectrum parenteral antimicrobials against common infections of childhood: a prospective and randomised comparison between penicillin and cefuroxime. Eur J Pediatr 2000 Dec; 159(12): 878–84

    Article  PubMed  CAS  Google Scholar 

  40. Manfredi R, Jannuzzi C, Mantero E, et al. Clinical comparative study of azithromycin versus erythromycin in treatment of acute respiratory tract infections in children. J Chemother 1992; 4: 364–70

    PubMed  CAS  Google Scholar 

  41. Block S, Hendrick J, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J 1995; 14: 471–7

    Article  PubMed  CAS  Google Scholar 

  42. Rojas MX, Granados C. Oral antibiotics versus parenteral antibiotics for severe pneumonia in children. Cochrane Database Syst Rev 2006; (2): CD004979

    Google Scholar 

  43. Campbell H, Byass P, Forgie IM, et al. Trial of co-trimoxazole versus procaine penicillin with ampicillin in treatment of community-acquired pneumonia in young Gambian children. Lancet 1988; 2(8621): 1182–4

    Article  PubMed  CAS  Google Scholar 

  44. Addo-yobo E, Chisaka N, Hassan M, et al. APPIS Group. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. Lancet 2004; 364(9440): 1141–8

    Article  PubMed  CAS  Google Scholar 

  45. Atkinson M, Lakhanpaul M, Smyth A, et al. A multicenter randomised controlled equivalence trial comparing oral amoxicillin and intravenous benzylpenicillin for community acquired pneumonia in children: PIVOT trial. Thorax Online. Epub 2007 Jun 13

    Google Scholar 

  46. Agarwal G, Awasthi S, Kabra SK, et al. ISCAP Study Group. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ 2004; 328(7443): 791–4

    Article  PubMed  Google Scholar 

  47. Hazir T, Quasi S, Nisar YB. Comparison of standard versus double dose of amoxicillin in the treatment of son-severe pneumonia in children aged 2–59 months: a multicentre, double blind, randomized controlled trial in Pakistan. Arch Dis Child 2007; 92(4): 291–7

    Article  PubMed  Google Scholar 

  48. Melander E, Ekdahl K, Jonsson G, et al. Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr Infect Dis J 2000; 19(12): 1172–7

    Article  PubMed  CAS  Google Scholar 

  49. Guillemot D, Varon E, Bernede C, et al. Reducion of antibiotic use in the community reduces the rate of colonization with penicillin g-nonsusceptible Streptococcus pneumoniae. Clin Infect Dis 2005 Oct; 14(7): 930–8

    Article  Google Scholar 

  50. Kellner JD. Drug-resistant Streptococcus pneumoniae infections: clinical importance, drug treatment and prevention. Semin Resp Infect 2001; 16: 186–95

    Article  CAS  Google Scholar 

  51. Deeks SL, Palacio R, Ruvinsky R, et al. Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group. Pediatrics 1999; 103: 409–13

    Article  PubMed  CAS  Google Scholar 

  52. Amsden GW. Pneumococcal macrolide resistance: myth or reality. J Antimicrob 1999; 44: 1–6

    Article  CAS  Google Scholar 

  53. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997; 337: 441–6

    Article  PubMed  CAS  Google Scholar 

  54. Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 2002; 34: 434–40

    Article  PubMed  Google Scholar 

  55. Rees JH, Spencer DA, Parikh D, et al. Increase in incidence of childhood empyema in West Midlands, UK [letter]. Lancet 1997; 349: 402

    Article  PubMed  CAS  Google Scholar 

  56. Byington CL, Korgenski K, Daky J, et al. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 2006; 24: 250–4

    Google Scholar 

  57. Donnelly LF, Klosterman LA. CT appearance of parapneumonic effusions in children: findings are not specific for empyema. Am J Roentgenol 1997; 169: 179–82

    CAS  Google Scholar 

  58. Avansino JR, Dennis TR, Spallone P, et al. Primary operative versus nonoperative therapy for pediatric empyema: a meta-analysis. Pediatrics 2005; 115: 1652–9

    Article  PubMed  Google Scholar 

  59. Thomson AH, Hull J, Kumar MR, et al. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 2002; 57: 343–7

    Article  PubMed  CAS  Google Scholar 

  60. Barnes NP, Hull J, Thomson AH. Medical management of parapneumonic pleural disease. Pediatr Pulmonol 2006; 39: 127–34

    Article  Google Scholar 

  61. Wells RG, Havens PL. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Radiology 2003; 228: 370–8

    Article  PubMed  Google Scholar 

  62. Sonnappa S, Cohen G, Owens C, et al. Comparison of urokinase and video-assisted thorascopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med 2006; 174: 221–7

    Article  PubMed  Google Scholar 

  63. Kurt BA, Winterhalter KM, Connors RH, et al. Therapy of parapneumonic effusions in children: video-assisted thoracoscopic surgery versus conventional thoracostomy drainage. Pediatrics 2006; 118: 547–53

    Article  Google Scholar 

  64. Gates RL, Hogan M, Weinstein S, et al. Drainage, fibrinolytics, or surgery: a comparison of treatment options in pediatric empyema. J Pediatr Surg 2004; 39: 1638–42

    Article  PubMed  Google Scholar 

  65. Suchar AM, Zureikat AH, Glynn L, et al. Ready for the frontline: is early thoracoscopic decortication the new standard of care for advanced pneumonia with empyema? Am Surg 2006; 72: 688–92

    PubMed  Google Scholar 

  66. Chang YT, Dai ZK, Lao EL, et al. Thoracoscopic decortication: first-line therapy for pediatric empyema. Eur Surg Res 2005; 37: 18–21

    Article  PubMed  Google Scholar 

  67. Cohen G, Hjortdal V, Ricci M, et al. Primary thoracoscopic treatment of empyema in children. J Thorac Cardiovasc Surg 2003; 125: 79–84

    Article  PubMed  Google Scholar 

  68. Tseng Yl, Wu MH, Lin MY, et al. Surgery for lung abscess in immunocompetent an immunocompromised patients. J Pediatr Surg 2001; 36: 470–3

    Article  PubMed  CAS  Google Scholar 

  69. Sleeman K, Knox K, George R, et al. Invasive pneumococcal disease in England and Wales: vaccination implication. J Infect Dis 2001; 183: 239–46

    Article  PubMed  CAS  Google Scholar 

  70. Black SB, Shinefiel HR, Ling S, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia. Pediatr Infect Dis J 2001; 21: 810–5

    Google Scholar 

  71. Esposito S, Lizioli A, Lastrico A, et al. Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age. Respir Res 2007; 21(8): 12–20

    Article  Google Scholar 

Download references

Acknowledgments

No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.

Author information

Authors and Affiliations

  1. Department of Paediatrics, John Radcliffe Hospital, Headington, Headley Way, Oxford, OX3 9DU, UK

    Krishne Chetty &  Anne H. Thomson

Authors
  1. Krishne Chetty
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne H. Thomson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anne H. Thomson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chetty, K., Thomson, A.H. Management of Community-Acquired Pneumonia in Children. Pediatr Drugs 9, 401–411 (2007). https://doi.org/10.2165/00148581-200709060-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00148581-200709060-00007

Keywords

Search

Navigation